Literature DB >> 15070918

Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency.

Alberto Falorni1, Stefano Laureti, Annamaria De Bellis, Renato Zanchetta, Claudio Tiberti, Giorgio Arnaldi, Vittorio Bini, Paolo Beck-Peccoz, Antonio Bizzarro, Francesco Dotta, Franco Mantero, Antonio Bellastella, Corrado Betterle, Fausto Santeusanio.   

Abstract

Primary adrenal insufficiency (PAI) is clinically evident in one in 8000 individuals. A correct etiological classification is critical for correct disease management. To update the diagnostic criteria for the etiological classification of PAI, a multicentric network was established in Italy, and 222 patients with PAI were studied. Both 21-hydroxylase and adrenal cortex autoantibodies (21OHAb and ACA, respectively) were tested in two independent laboratories on coded samples and found in 65-66% and 58-61% of cases, respectively. Autoimmune polyendocrine syndrome I was diagnosed in 11 of the 222 patients. Of the remaining 211 patients, 38 (18%) had a nonautoimmune form of PAI. In 145 subjects (65%), the presence of adrenal autoantibodies, without signs of other forms of PAI, led to a diagnosis of autoimmune Addison's disease. In six cases (3%), PAI remained idiopathic. Logistic regression analysis showed a 92.2-92.7% probability of correct reclassification for the two 21OHAb assays and 84.5-85.9% for the ACA assays. We conclude that the simultaneous presence of both 21OHAb and ACA permits unambiguous diagnosis of autoimmune Addison's, whereas subjects with low antibody titers should undergo both instrumental and biochemical tests to exclude other causes of PAI. Lastly, we developed a comprehensive flowchart for the classification of PAI for use in routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070918     DOI: 10.1210/jc.2003-030954

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Predicting the onset of Addison's disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies.

Authors:  Peter R Baker; Priyaanka Nanduri; Peter A Gottlieb; Liping Yu; Georgeanna J Klingensmith; George S Eisenbarth; Jennifer M Barker
Journal:  Clin Endocrinol (Oxf)       Date:  2012-05       Impact factor: 3.478

2.  Dominant suppression of Addison's disease associated with HLA-B15.

Authors:  Peter R Baker; Erin E Baschal; Pam R Fain; Priyaanka Nanduri; Taylor M Triolo; Janet C Siebert; Taylor K Armstrong; Sunanda R Babu; Marian J Rewers; Peter A Gottlieb; Jennifer M Barker; George S Eisenbarth
Journal:  J Clin Endocrinol Metab       Date:  2011-05-11       Impact factor: 5.958

Review 3.  Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events.

Authors:  Elisa González-Rodríguez; Delvys Rodríguez-Abreu
Journal:  Oncologist       Date:  2016-06-15

4.  Simultaneous evaluation of the circulating levels of both Th1 and Th2 chemokines in patients with autoimmune Addison's disease.

Authors:  G Bellastella; M Rotondi; E Pane; S Costantini; C Colella; R Calemma; F Capone; A Falorni; G Castello; A A Sinisi; A Bizzarro; L Chiovato; A Bellastella; A De Bellis
Journal:  J Endocrinol Invest       Date:  2010-12-15       Impact factor: 4.256

Review 5.  Therapy of adrenal insufficiency: an update.

Authors:  Alberto Falorni; Viviana Minarelli; Silvia Morelli
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

6.  Addison's Disease Revisited in Poland: Year 2008 versus Year 1990.

Authors:  Anna A Kasperlik-Zaluska; Barbara Czarnocka; Wojciech Jeske; Lucyna Papierska
Journal:  Autoimmune Dis       Date:  2010-06-06

Review 7.  Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults.

Authors:  C Betterle; F Presotto; J Furmaniak
Journal:  J Endocrinol Invest       Date:  2019-07-18       Impact factor: 5.467

8.  Primary adrenal insufficiency in adult population: a Portuguese Multicentre Study by the Adrenal Tumours Study Group.

Authors:  Lia Ferreira; João Silva; Susana Garrido; Carlos Bello; Diana Oliveira; Hélder Simões; Isabel Paiva; Joana Guimarães; Marta Ferreira; Teresa Pereira; Rita Bettencourt-Silva; Ana Filipa Martins; Tiago Silva; Vera Fernandes; Maria Lopes Pereira
Journal:  Endocr Connect       Date:  2017-10-31       Impact factor: 3.335

Review 9.  Autoimmune Addison's Disease as Part of the Autoimmune Polyglandular Syndrome Type 1: Historical Overview and Current Evidence.

Authors:  Roberto Perniola; Alessandra Fierabracci; Alberto Falorni
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 10.  Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic.

Authors:  Agnese Barnabei; Paola Senes; Alessandro Scoppola; Alfonsina Chiefari; Giovanni Maria Iannantuono; Marialuisa Appetecchia; Francesco Torino
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.